Showing results (2151-2160 of 2,925) with videos related to

Sort By:
Pageof 293
JAMA Oncology|November 4, 2021
Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy Among Trial-Ineligible Patients With Advanced Solid CancersRavi B Parikh, Eun Jeong Min, E Paul Wileyto, et al.
Arthritis Care & Research|October 9, 2018
Brief Report: Safety and Immunogenicity of Rituximab Biosimilar GP 2013 After Switch From Reference Rituximab in Patients With Active Rheumatoid ArthritisHans-Peter Tony, Klaus Krüger, Stanley B Cohen, et al.
The American Journal of Gastroenterology|September 23, 2003
Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trialDavid A Johnson, Robert Ganz, James Aisenberg, et al.
The Journal of Biological Chemistry|July 2, 2002
Bisindolylmaleimide IX facilitates tumor necrosis factor receptor family-mediated cell death and acts as an inhibitor of transcriptionOskar W Rokhlin, Rebecca A Glover, Agshin F Taghiyev, et al.
British Journal of Cancer|February 7, 2001
A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancerI E Young, K M Kurian, M A MacKenzie, et al.
Molecular Therapy. Methods & Clinical Development|February 12, 2020
Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing AntibodiesCeren Tuzmen, Tina M Cairns, Doina Atanasiu, et al.
Academic Pathology|October 17, 2022
Features of burnout amongst pathologists: A reassessmentMichael B Cohen, Marisa Saint Martin, David J Gross, et al.
Clinical and Vaccine Immunology : CVI|September 20, 2013
Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coliSamer S El-Kamary, Mitchell B Cohen, A Louis Bourgeois, et al.
RMD Open|May 28, 2021
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposureGerd R Burmester, Peter Nash, Bruce E Sands, et al.
The Oncologist|August 2, 2019
Improving Cancer Diagnosis and Care: Patient Access to High-Quality Oncologic PathologySharyl J Nass, Michael B Cohen, Ritu Nayar, et al.
Pageof 293